blocking monoclonal antibodies (Expression Drug Designs)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameblocking monoclonal antibodies (Expression Drug Designs)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExpression Drug Designs LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExpression Drug Designs LLC
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A